News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Iverson Genetic Diagnostics Offers FDA Cleared Warfarin Test


3/5/2008 11:00:16 AM

SEATTLE--(BUSINESS WIRE)--Iverson Genetic Diagnostics, Inc. announced today that it offers physicians and their patients two types of molecular-based assays for testing warfarin (brand name, Coumadin) sensitivity. One has received Food and Drug Administration clearance and genetically tests a patient’s blood for this sensitivity, with results returned in 2-5 days. The second assay tests a sample of the patient’s saliva and requires only one to two days before test results are made available.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES